In a never-before-seen effort, taxonomy, treatment, targets and remission (3TR) sets out to fundamentally increase our knowledge of the molecular pathways and mechanisms linked to response and non-response to therapy in seven different immune-mediated, allergic and inflammatory diseases. 3TR is the largest immunology project funded by the Innovative Medicine Initiative (IMI) to date.
Next ProjectPer-protocol repeat kidney biopsy in incident cases of lupus nephritis (ReBioLup)
